Alps Advisors Inc Vascular Biogenics Ltd. Transaction History

Alps Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 25, 2018	SELL	$2.05 - $3.0 $14,206 - $20,790	-6,930 Reduced 17.38%	32,938 $234,000
Q1 2018 May 01, 2018	BUY	$2.27 - $8.5 $15,731 - $58,905	6,930 Added 21.04%	39,868 $92,000
Q4 2017 Feb 05, 2018	BUY	$5.65 - $9.0 $186,099 - $296,442	32,938	32,938 $234,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.